EB病毒衣殼IgG免疫熒光玻片試劑盒

EBV Viral Capsid IgG IFA Kit

廣州健侖生物科技有限公司

主要用途：用于檢測人血清中的EB病毒衣殼IgG抗體

產(chǎn)品規(guī)格：12 孔/張,10 張/盒

主要產(chǎn)品包括：包柔氏螺旋體菌、布魯氏菌、貝納特氏立克次體、土倫桿菌、鉤端螺旋體、新型立克次體、恙蟲病、立克次體、果氏巴貝西蟲、馬焦蟲、牛焦蟲、利什曼蟲、新包蟲、弓形蟲、貓流感病毒、貓冠狀病毒、貓皰疹病毒、犬瘟病毒、犬細(xì)小病毒等病原微生物的 IFA、MIF、ELISA試劑。

EB病毒衣殼IgG免疫熒光玻片試劑盒

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無形體、蜱蟲、恙蟲、利什曼原蟲、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號二期2幢101-3室
【企業(yè)文化】

2014年8月11日Developmental Cell期刊封面顯示泌乳鼠類抗原抗體產(chǎn)物免疫熒光染色法E-鈣粘蛋白(棕色)和αSMA(紅色)。這種產(chǎn)物來自整聯(lián)蛋白αvβ3表達(dá)上皮細(xì)胞從懷孕供體小鼠獲得。
科學(xué)家已經(jīng)可以誘導(dǎo)干細(xì)胞形成視網(wǎng)膜，這為很多眼疾患者帶來希望。
在子宮里，一團(tuán)相同的細(xì)胞分化成各種不同的模樣，zui終形成高度有序的結(jié)構(gòu)，組裝成人體的全副器官。這個過程依照內(nèi)在的“生物學(xué)藍(lán)圖”有條不紊地進(jìn)行，引導(dǎo)組織產(chǎn)生折疊、皺褶，精確形成適當(dāng)?shù)耐庑魏痛笮　?br />科學(xué)家很熟悉這個由簡單到復(fù)雜的進(jìn)程，他們一直在思索胚胎發(fā)育的機(jī)制，暗自驚嘆它的奧妙，又渴望在實驗臺上重演早期發(fā)育階段——既為了更好地理解其中的生物學(xué)機(jī)制，也為了將這些信息應(yīng)用于修復(fù)和替代受損組織。這個時刻或許已到來了。解密發(fā)育奧妙的工作zui近取得了不少成就，體外培養(yǎng)的替代器官有望在10年內(nèi)就進(jìn)入手術(shù)室。
之所以作出如此樂觀的預(yù)測，是因為我的實驗室近來在干細(xì)胞研究上取得了一些成果。干細(xì)胞會分化成其他類型的細(xì)胞。我們發(fā)現(xiàn)，即使在體外培養(yǎng)的環(huán)境下，干細(xì)胞也可以分化形成視網(wǎng)膜——眼睛里的關(guān)鍵結(jié)構(gòu)之一，它把來自外部世界的光信號，轉(zhuǎn)換成電信號和化學(xué)信號，繼而傳遞給大腦的其他部位。此外，我和同事還培植出了皮層組織，以及垂體的一部分。由于我們對人體信號傳導(dǎo)系統(tǒng)的認(rèn)識越來越深入，因此在做上述研究時，我們根據(jù)自己掌握的知識，對培養(yǎng)皿中的一層相互分離的細(xì)胞進(jìn)行誘導(dǎo)，讓它們形成了一種輪廓分明的三維結(jié)構(gòu)。其實，這些細(xì)胞收到我們“輸入”的化學(xué)信號后，自己就會行動起來，開始建造視網(wǎng)膜。這一研究成果讓很多人看到了希望：用這種方法制備的視網(wǎng)膜組織有望用于治療黃斑變性等多種眼疾。

August 11, 2014 Developmental Cell Journal Cover shows lactogenic murine antigen antibody product immunofluorescence staining E-cadherin (brown) and αSMA (red). This product is derived from integrin αvβ3-expressing epithelial cells from pregnant donor mice.
Scientists have been able to induce the formation of retinal stem cells, which brings hope for many patients with eye diseases.
In the womb, a group of the same cells differentiate into different shapes, eventually forming a highly ordered structure, assembled into the human organ. The process is conducted in an orderly manner based on the inherent "biological blueprint," guiding the organization to produce folds, folds, and precise shapes and sizes.
Scientists are familiar with this simple to complex process, they have been pondering the mechanism of embryonic development, secretly marveling its mystery, but also eager to repeat the early stages of development on the experimental stage - both to better understand the biological mechanisms, Also to apply this information to repair and replace damaged tissue. This moment may have come. Recently, a lot of achievements have been made in the work of deciphering the development and the alternative organs cultured in vitro are expected to enter the operating room within 10 years.
The reason for such optimistic predictions is that my lab has made some achievements in stem cell research lay. Stem cells differentiate into other types of cells. We found that stem cells can differentiate to form the retina, even in in vitro culture environments - one of the key structures in the eye that converts light signals from the outside into electrical and chemical signals that are then passed on to the brain's other Site. In addition, my colleagues and I also c*ted cortical tissue, as well as part of the pituitary gland. As our knowledge of the human signaling system becomes more and more in-depth, based on our own knowledge, we conduct a study of the cells in the Petri dish that are separated from each other, giving them a well- The three-dimensional structure. In fact, when these cells receive our "input" chemical signal, they will act and begin to build the retina. The results of this research so that many people see the hope: Retinal tissue prepared by this method is expected to be used to treat macular degeneration and other eye diseases.